CB
Cibus, Inc. (CBUS)
NASDAQ·Healthcare·Biotechnology
$1.20
+1.69%
Mkt Cap $81.42M
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$11.50
Range $10.50 – $12.50
Implied Upside
+858.3%
Consensus $11.50 vs current $1.20
NASDAQ·Healthcare·Biotechnology
$1.20
+1.69%
Mkt Cap $81.42M
No recent rating data.
Price Target (3 analysts)
$11.50
Range $10.50 – $12.50
+858.3%
Consensus $11.50 vs current $1.20